Drugs / INTANZA® 15
last change Apr 2013 re-read 2 minutes ago

INTANZA® 15

Vaccine

Developed for
influenza
Investigated by
Assistance Publique - Hôpitaux de Paris · French National Institute of Health and Medical Research

Trials 1 · a red edge is where a trial was stopped

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01707602 Oct → Dec 2012 influenza Assistance Publique - Hôpitaux de Paris Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as INTANZA 15 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01707602
Modality Vaccine “seasonal influenza vaccination” NCT01707602